Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. - Wikidata - wikimedia - TriplyDB

Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

http://www.wikidata.org/entity/Q36889928

about

Clinical review: sepsis and septic shock--the potential of gene arrays Diagnosing sepsis - The role of laboratory medicine.Biomarker discovery and development in pediatric critical care medicine.Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept.Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock.Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum.Identification of pediatric septic shock subclasses based on genome-wide expression profiling.The pediatric sepsis biomarker risk model.Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study.Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.Pathophysiology and treatment of septic shock in neonates.Leukocyte subset-derived genomewide expression profiles in pediatric septic shock New approaches to sepsis: molecular diagnostics and biomarkers.Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis.Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock The temporal version of the pediatric sepsis biomarker risk model.Validation of a gene expression-based subclassification strategy for pediatric septic shock.Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock.Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers.The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.Genome-wide expression profiling in pediatric septic shock.Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children Cytokine Profiles during Invasive Nontyphoidal Salmonella Disease Predict Outcome in African Children.Bacterial phenotype variants in group B streptococcal toxic shock syndrome Ceramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells.Role of biomarkers in sepsis care.IL-8 signaling does not mediate intra-amniotic LPS-induced inflammation and maturation in preterm fetal lamb lung.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model.Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis.The Value of Admission Serum IL-8 Monitoring and the Correlation with IL-8 (-251A/T) Polymorphism in Critically Ill Patients.Mechanisms and regulation of the gene-expression response to sepsis.Biomarkers for pediatric sepsis and septic shock.Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.Genetics and genomics in pediatric septic shock.Diagnosis and management of hypotension in neonates.Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies.Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.Emerging infection and sepsis biomarkers: will they change current therapies?

P2860

Q26864138-BC70249A-D56B-4AB1-9246-6EC373E3B58C Q30249127-2D26D4F9-CE9B-4A5F-B938-CE774C7BEEB4 Q30428168-53B649CF-2AB9-4A90-BA20-120596129C99 Q30430434-F87863D9-5E93-440B-85F7-73164630D887 Q30433097-333B353F-26DA-4751-820C-034A2B7597AF Q30436233-5D650407-8EC4-4A49-9D3C-FD13ADA9652A Q30438982-80FD04D1-909A-40DC-A9D7-34C9DC3A2CB3 Q30540641-57C35D57-0C73-4748-A642-733B09AB94D0 Q33636815-F45523FC-E5DE-413C-B90E-82176F2FCF0F Q33901670-5363BCDE-A80A-4981-BD7B-D96DD0BD464D Q33940492-E80BD0AE-271D-479E-ADBF-AC11A78880D7 Q34082462-0EF383BD-5E9D-4A34-81AF-F5C048D1B8A2 Q34303687-BF8B5B98-42D2-4C9D-90F9-6105791653B9 Q34490041-210F6320-7C09-476E-B401-6BC0C70181D2 Q34587242-8A296C51-3672-4473-938F-7421D11DEF15 Q35120147-FEE3E679-5349-43DA-B367-FB32531DCA80 Q35387550-3330813B-E3DE-47E6-A883-D06F513EBEE8 Q35946158-BAAC0587-6D17-407C-B123-100DA1043D8D Q36073048-132B6AA3-3871-4210-8AC4-A11DD0D5D65C Q36181988-A410C277-0B69-4AAE-865D-9F8CAA66C55C Q36341842-53B29F24-D9AB-44A8-A370-3B4D254B6293 Q36735992-67EFA1EA-4EDF-47AB-BF44-4653F584A4F2 Q36928294-5F66F12A-5A33-425F-8732-491733E9C394 Q37067282-704C2F22-57BC-4809-95B7-3FA84608BBD3 Q37133323-42C425A0-249C-47C9-9326-3F462853B3DA Q37190216-6065D0B8-C4A6-40D2-A00C-F1F8F55D5F63 Q37249625-7535EDF8-F82D-4E54-B84F-B4294AAA22FE Q37337516-2BDF5823-25D7-4758-B087-2F19E64A3B1D Q37367885-DD18AE1D-3342-48A0-BB9E-64C3FA60928F Q37529311-E3BB6B32-07B2-4AAA-B5D0-FD83234D0C3E Q37625638-0DB06A62-96CF-43B5-8F67-83FF502B762A Q37657433-ED40F59D-0370-42CC-9BE6-D728D5CFCB68 Q37755880-DC44B7FB-51B7-4ECE-9EB3-41DB8CC3B065 Q37822454-F661EFA6-0FC9-4967-980C-8631133F40F5 Q37858108-5587A1F4-2EC3-4CDB-958E-5BBB9F66BA92 Q38003324-D07CB623-2F92-45F6-B6D5-E5001B738180 Q38135892-2BF914AB-8836-42DC-9140-73E43F62E57D Q38488118-836553FC-3CBF-4A05-A41A-2E79F51B4E02 Q38815368-B3FCA3B3-E2C5-4E31-B1B7-7664E3C1002A Q38929971-7366E031-2A19-4C21-8854-0F112B5270E3

P2860

Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

http://www.wikidata.org/entity/Q36889928

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Interleukin-8 as a stratificat ...... olving pediatric septic shock.

@en

type

label

Interleukin-8 as a stratificat ...... olving pediatric septic shock.

@en

prefLabel

Interleukin-8 as a stratificat ...... olving pediatric septic shock.

@en

P1433

Q36889928-A3F12398-FBA8-4919-BB2F-F22A9698B309

P1476

Q36889928-11F84FD8-2FB3-4771-932F-DEC968FA1491

P2093

Q36889928-06BD8227-0753-458B-B270-C34B79C3616C

Q36889928-06C66806-F578-4E75-B2FE-7B57C5526835

Q36889928-2B5FFC53-FB82-4935-BE51-05DAD102AC1A

Q36889928-3310BAC7-33C1-4EA3-8C4D-D7DDDC67E87E

Q36889928-33622BF2-093E-4181-B0A5-7E4A64B7795C

Q36889928-532D8150-CFB1-4F74-A5D8-6D947C16FDB3

Q36889928-62E73D52-8087-4005-8EA7-8C2AA4F49C88

Q36889928-D9459490-3CF0-4DD8-A5CF-9B69B605DE03

P2860

Q36889928-06E1A563-F16E-4DF8-A3F6-849F1C8B0C96

Q36889928-257A7F7C-0C81-44C0-82D4-7078FD0C9C5E

Q36889928-3BBFB223-D3A7-4A8D-B174-75DC089BBCB5

Q36889928-49CBB973-A155-4E6E-8F05-A1FA0C1711BD

Q36889928-4CE640C2-52EA-4BA8-BD30-72D274DCA302

Q36889928-4CE8423E-57C7-4382-95E8-A933DEE97C7A

Q36889928-5458CC26-693A-4D64-AB93-FAC6B8D2304C

Q36889928-5909B4F8-EE63-42F9-B2B2-491194F8BAD5

Q36889928-5C12F247-6B52-47D4-A92B-8D79C852026E

Q36889928-67A96625-D7E9-4402-9650-22779C3C9BEE

P304

Q36889928-9A23B9EA-429F-4B41-ACB5-2A8E1BF3365D

P31

Q36889928-FD22FB28-75FD-493F-8A7F-143B1C738CF1

P356

Q36889928-34CFF895-5095-40A4-82AB-7BE867DFC68A

P407

Q36889928-5CCA9A30-51FA-43E1-8706-5507F4C25025

P433

Q36889928-ACB5BFF8-EB1A-4A8B-A8D5-A24D737CB88F

P478

Q36889928-034B58E2-E027-4A54-930B-ADA6FC991C70

P577

Q36889928-72FEFE11-C817-4E47-A954-F8C0A4D3A067

P5875

Q36889928-446D6257-89A8-4552-9339-A9947C6BE1F6

P698

Q36889928-B70B9740-DD18-4CEB-AA10-03EC6020BFC2

P921

Q36889928-13A7DD5A-35AA-4936-BE5D-5DD4F9FC0533

P932

Q36889928-F24A2C26-5631-44BD-B130-565AD70CB3F3

P356

RCCM.200801-131OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Interleukin-8 as a stratificat ...... olving pediatric septic shock.

@en

P2093

Derek S Wheeler

http://www.w3.org/2001/XMLSchema#string

Hector R Wong

http://www.w3.org/2001/XMLSchema#string

Kelli Odoms

http://www.w3.org/2001/XMLSchema#string

Marie Monaco

http://www.w3.org/2001/XMLSchema#string

Mark D Williams

http://www.w3.org/2001/XMLSchema#string

Michael T Bigham

http://www.w3.org/2001/XMLSchema#string

Natalie Cvijanovich

http://www.w3.org/2001/XMLSchema#string

William L Macias

http://www.w3.org/2001/XMLSchema#string

P2860

G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847].

Time course of endothelial damage in septic shock: prediction of outcome.

The problem of secondary contamination following chemical agent release.

Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome.

Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.

International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Multiplexed microsphere-based flow cytometric assays.

Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock.

Scope and epidemiology of pediatric sepsis.

Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum.

P304

276-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200801-131OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5338681

http://www.w3.org/2001/XMLSchema#string

P698

18511707

http://www.w3.org/2001/XMLSchema#string

P921

P932

2542425

http://www.w3.org/2001/XMLSchema#string